Analysis for BAC
- 📈 Growth — 26/30
- 💰 Profitability — 19/20
- 🏦 Financial Health — 16/20
- 💵 Valuation — 15/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
From 2024 Q3 to 2026 Q2, revenues rose from about $25.35B to $31.56B, a gain of roughly $6.21B (~24%). Net income grew from about $7.40B to $9.07B, up ~23%. The path shows a mid-period dip in 2025 Q2 revenue, then a strong upturn into 2025 Q3–2026 Q2, with earnings accelerating in late 2025 and remaining solid in 2026.
💰 Margins & Cash Flow
Operating margin expanded from about 29% in 2024 Q3 to the mid-to-high 30s and into the high 30s/40% range in late 2025, signaling improved operating leverage. Net interest income and noninterest income underpin the margin, with operating income rising in each later quarter. Cash flow swung from negative in several 2024–2025 quarters to a robust positive in 2026 Q2, where Net Cash Flow From Operating Activities was about $29.0B, complemented by sizable financing activity in late 2025 and a core investment program.
🛡️ Balance Sheet & Liquidity
Assets run around $3.3T–$3.5T with equity near $296–$301B and long-term debt of about $311–$339B. Liabilities are substantial but matched by ample liquidity and a strong capital base, yielding a resilient balance sheet across the period.
⚠️ Key Drivers & Risks
- Drivers: 1) favorable NII in a higher-rate regime; 2) stable deposit base and loan demand.
- Risks: 1) macroeconomic credit risks/cyclicality; 2) sensitivity to rate/valuation shifts and regulatory dynamics.